Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

542
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
542
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

524
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
524
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

575
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
575
Neural Regulation01:37

Neural Regulation

44.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.0K
Peripheral Nervous System: Ganglia and Nerves01:24

Peripheral Nervous System: Ganglia and Nerves

6.8K
The Peripheral Nervous System (PNS) is a crucial component of the body's neural network, extending beyond the central nervous system (CNS) to bridge the gap between the CNS and the external environment. It encompasses nerves, ganglia, and sensory receptors.
Nerves
The nerve is a bundle of axons that serves as the communication highway in the PNS. Each nerve is ensheathed in a protective layer of connective tissue called the epineurium. This outermost layer safeguards the nerve and supports the...
6.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The distribution of acquired peripheral nerve injuries associated with severe COVID-19 implicate a mechanism of entrapment neuropathy: a multicenter case series and clinical feasibility study of a wearable, wireless pressure sensor.

Journal of neuroengineering and rehabilitation·2022
Same author

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG).

The Lancet. Neurology·2020
Same author

Differentiation between neurosarcoidosis and primary central nervous system vasculitis based on demographic, cerebrospinal and imaging features.

Clinical and experimental rheumatology·2020
Same author

Office approach to small fiber neuropathy.

Cleveland Clinic journal of medicine·2018
Same author

Immune Axonal Polyneuropathy.

Continuum (Minneapolis, Minn.)·2017
Same author

Low Back Pain.

Continuum (Minneapolis, Minn.)·2017
Same journal

Distinguishing drug-target effects from natural lipid variation and incorporating imaging outcomes in Mendelian randomisation studies of multiple sclerosis.

Journal of the neurological sciences·2026
Same journal

Long-term social cognitive impairment after ischemic stroke: Frequency and association with lesion volume and location in an exploratory pilot study.

Journal of the neurological sciences·2026
Same journal

Subjective cognitive decline among U.S. Cancer survivors, 2017-2024: Prevalence, cancer-specific patterns, and associated factors.

Journal of the neurological sciences·2026
Same journal

Comment on "Comparative impact of mental and cardiovascular comorbidities on adverse outcomes in people with MS".

Journal of the neurological sciences·2026
Same journal

Comment on "Efficacy and safety of conventional immunosuppressant therapies in elderly patients with Neuromyelitis optica spectrum disorder: A target trial emulation study".

Journal of the neurological sciences·2026
Same journal

Increasing incidence of varicella-zoster virus meningitis in Japan, 2011-2022.

Journal of the neurological sciences·2026
See all related articles

Related Experiment Video

Updated: Mar 13, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

10.2K

Smart device neuropathy.

Karen A Karwa1, Donika Patel2, Jinny O Tavee3

  • 1Neuromuscular Center, Cleveland Clinic Foundation, 9500 Euclid Ave S90, Cleveland, OH 44195, United States; National Jewish Health, 1400 Jackson Street, Denver, CO 80206, United States.

Journal of the Neurological Sciences
|October 25, 2016
PubMed
Summary
This summary is machine-generated.

Meralgia paresthetica, or lateral femoral cutaneous nerve (LFCN) compression, can be caused by modern lifestyle factors. This study highlights two cases where smart devices compressed the LFCN, leading to this condition.

Keywords:
Lateral femoral cutaneous nerveMeralgia parestheticaNeuropathySmart device

More Related Videos

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

2.5K
Fabrication of the Composite Regenerative Peripheral Nerve Interface C-RPNI in the Adult Rat
10:35

Fabrication of the Composite Regenerative Peripheral Nerve Interface C-RPNI in the Adult Rat

Published on: February 25, 2020

8.8K

Related Experiment Videos

Last Updated: Mar 13, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

10.2K
Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

2.5K
Fabrication of the Composite Regenerative Peripheral Nerve Interface C-RPNI in the Adult Rat
10:35

Fabrication of the Composite Regenerative Peripheral Nerve Interface C-RPNI in the Adult Rat

Published on: February 25, 2020

8.8K

Area of Science:

  • Neurology
  • Medical Devices

Background:

  • Meralgia paresthetica is a condition caused by compression of the lateral femoral cutaneous nerve (LFCN).
  • Common causes include obesity, pregnancy, and tight clothing.
  • The LFCN supplies sensation to the anterolateral thigh.

Observation:

  • Two cases of meralgia paresthetica were identified.
  • The compression of the LFCN in both cases was attributed to the use of portable electronic or "smart" devices.
  • These devices were positioned in a manner that exerted pressure on the nerve.

Findings:

  • Portable electronic devices can act as an external factor causing LFCN compression.
  • This represents a novel etiology for meralgia paresthetica.
  • Symptoms of meralgia paresthetica may arise from prolonged contact with smart devices.

Implications:

  • Awareness among clinicians and patients regarding device-induced nerve compression is crucial.
  • Patients presenting with thigh paresthesia should be questioned about their use of portable electronic devices.
  • Recommendations for device usage may need to be updated to prevent nerve entrapment syndromes.